Failure of viral oncoproteins to target the p53-homologue p51A

Journal of General Virology

Volumn 80, Issue 12, 1999, Pages 3251-3255

  Roth, Judith ^a   Dobbelstein, Matthias ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ONCOPROTEIN; PROTEIN P53; VIRUS LARGE T ANTIGEN; VIRUS PROTEIN;

ARTICLE; CANCER INHIBITION; CELL NUCLEUS; CYTOPLASM; PRIORITY JOURNAL; SIMIAN VIRUS 40; TRANSCRIPTION INITIATION;

DNA VIRUSES; HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 18; RNA VIRUSES; SIMIAE; SIMIAN VACUOLATING VIRUS; SIMIAN VIRUS; SIMIAN VIRUS 40; VACUOLATING VIRUS;

EID: 0032724420     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/0022-1317-80-12-3251     Document Type: Article

References (38)

1. Bian, J. & Sun, Y. (1997). p53CP, a putative p53 competing protein that specifically binds to the consensus p53 DNA binding sites: a third member of the p53 family? Proceedings of the National Academy of Sciences, USA 94, 14753-14758.
2. De Laurenzi, V., Costanzo, A., Barcaroli, D., Terrinoni, A., Falco, M., Annicchiarico-Petruzzelli, M., Levrero, M. & Melino, G. (1998). Two new p73 splice variants, gamma and delta, with different transcriptional activity. Journal of Experimental Medicine 188, 1763-1768.
3. Dobbelstein, M. & Roth, J. (1998). The large T antigen of simian virus 40 binds and inactivates p53 but not p73. Journal of General Virology 79, 3079-3083.
4. Dobbelstein, M., Wienzek, S., König, C. & Roth, J. (1999). Inactivation of the p53-homologue p73 by the mdm2-oncoprotein. Oncogene 18, 2101-2106.
5. Donehower, L. A., Harvey, M., Slagle, B. L., McArthur, M. J., Montgomery, C. A., Jr, Bute, J. S. & Bradley, A. (1992). Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature 356, 215-221.
6. Freedman, D. A., Epstein, C. B., Roth, J. C. & Levine, A. J. (1997). A genetic approach to mapping the p53 binding site in the MDM2 protein. Molecular Medicine 3, 248-259.
7. Henning, W., Rohaly, G., Kolzau, T., Knippschild, U., Maacke, H. & Deppert, W. (1997). MDM2 is a target of simian virus 40 in cellular transformation and during lytic infection. Journal of Virology 71, 7609-7618.
8. Higashino, F., Pipas, J. M. & Shenk, T. (1998). Adenovirus e4orf6 oncoprotein modulates the function of the p53-related protein, p73. Proceedings of the National Academy of Sciences, USA 95, 15683-15687.
9. Huibregtse, J. M., Scheffner, M. & Howley, P. M. (1991). A cellular protein mediates association of p53 with the E6 oncoprotein of human papillomavirus types 16 or 18. EMBO Journal 10, 4129-4135.
10. Jost, C. A., Marin, M. C. & Kaelin, W. G., Jr (1997). p73 is a human p53-related protein that can induce apoptosis. Nature 389, 191-194.
11. Kaelin, W. G., Jr (1998). Another p53 Doppelganger? Science 281, 57-58.
12. Kaghad, M., Bonnet, H., Yang, A., Creancier, L., Biscan, J. C., Valent, A., Minty, A., Chalon, P., Lelias, J. M., Dumont, X., Ferrara, P., McKeon, F. & Caput, D. (1997). Monoallelically expressed gene related to p53 at Ip36, a region frequently deleted in neuroblastoma and other human cancers. Cell 90, 809-819.
13. Kalderon, D., Richardson, W. D., Markham, A. F. & Smith, A. E. (1984a). Sequence requirements for nuclear location of simian virus 40 large-T antigen. Nature 311, 33-38.
14. Kalderon, D., Roberts, B. L., Richardson, W. D. & Smith, A. E. (1984b). A short amino acid sequence able to specify nuclear location. Cell 39, 499-509.
15. Levine, A. J. (1997). p53, the cellular gatekeeper for growth and division. Cell 88, 323-331.
16. Lin, J., Chen, J., Elenbaas, B. & Levine, A. J. (1994). Several Hydrophobic amino acids in the p53 amino-terminal domain are required for transcriptional activation, binding to mdm-2 and the adenovirus 5 E1B 55-kD protein. Genes & Development 8, 1235-1246.
17. Mai, M., Yokomizo, A., Qian, C., Yang, P., Tindall, D. J., Smith, D. I. & Liu, W. (1998). Activation of p73 silent allele in lung cancer. Cancer Research 58, 2347-2349.
18. Marin, M. C., Jost, C. A., Irwin, M. S., DeCaprio, J. A., Caput, D. & Kaelin, W. G., Jr (1998). Viral oncoproteins discriminate between p53 and the p53 homolog p73. Molecular and Cellular Biology 18, 6316-6324.
19. Mills, A. A., Zheng, B., Wang, X. J., Vogel, H., Roop, D. R. & Bradley, A. (1999). p63 is a p53 homologue required for limb and epidermal morphogenesis. Nature 398, 708-713.
20. Nomoto, S., Haruki, N., Kondo, M., Konishi, H. & Takahashi, T. (1998). Search for mutations and examination of allelic expression imbalance of the p73 gene at 1p36.33 in human lung cancers. Cancer Research 58, 1380-1383.
21. Osada, M., Ohba, M., Kawahara, C., Ishioka, C., Kanamaru, R., Katoh, I., Ikawa, Y., Nimura, Y., Nakagawara, A., Obinata, M. & Ikawa, S. (1998). Cloning and functional analysis of human p51, which structurally and functionally resembles p53. Nature Medicine 4, 839-843.
22. Prabhu, N. S., Somasundaram, K., Satyamoorthy, K., Herlyn, M. & El-Deiry, W. S. (1998). p73, unlike p53, suppresses growth and induces apoptosis of human papillomavirus E6-expressing cancer cells. International Journal of Oncology 13, 5-9.
23. Reichelt, M., Zang, K. D., Seifert, M., Welter, C. & Ruffing, T. (1999). The yeast two-hybrid system reveals no interaction between p73 alpha and SV40 large T-antigen. Archives of Virology 144, 621-626.
24. Roth, J., König, C., Wienzek, S., Weigel, S., Ristea, S. & Dobbelstein, M. (1998). Inactivation of p53 but not p73 by adenovirus type 5 E1B 55-kilodalton and E4 34-kilodalton oncoproteins. Journal of Virology 72, 8510-8516.
25. Scheffner, M., Werness, B. A., Huibregtse, J. M., Levine, A. J. & Howley, P. M. (1990). The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 63, 1129-1136.
26. Scheffner, M., Huibregtse, J. M., Vierstra, R. D. & Howley, P. M. (1993). The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53. Cell 75, 495-505.
27. Schmale, H. & Bamberger, C. (1997). A novel protein with strong homology to the tumor suppressor p53. Oncogene 15, 1363-1367.
28. Senoo, M., Seki, N., Ohira, M., Sugano, S., Watanabe, M., Tachibana, M., Tanaka, T., Shinkai, Y. & Kato, H. (1998). A second p53-related protein, p73L, with high homology to p73. Biochemical and Biophysical Research Communications 248, 603-607.
29. Steegenga, W. T., Shvarts, A., Riteco, N., Bos, J. L. & Jochemsen, A. G. (1999). Distinct regulation of p53 and p73 activity by adenovirus E1A, E1B, and e4orf6 proteins. Molecular and Cellular Biology 19, 3885-3894.
30. Sunahara, M., Ichimiya, S., Nimura, Y., Takada, N., Sakiyama, S., Sato, Y., Todo, S., Adachi, W., Amano, J. & Nakagawara, A. (1998). Mutational analysis of the p73 gene localized at chromosome 1p36.3 in colorectal carcinomas. International Journal of Oncology 13, 319-323.
31. Takahashi, H., Ichimiya, S., Nimura, Y., Watanabe, M., Furusato, M., Wakui, S., Yatani, R., Aizawa, S. & Nakagawara, A. (1998). Mutation, allelotyping, and transcription analyses of the p73 gene in prostatic carcinoma. Cancer Research 58, 2076-2077.
32. Trink, B., Okami, K., Wu, L., Sriuranpong, V., Jen, J. & Sidransky, D. (1998). A new human p53 homologue. Nature Medicine 4, 747-748.
33. Werness, B. A., Levine, A. J. & Howley, P. M. (1990). Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science 248, 76-79.
34. Yang, A., Kaghad, M., Wang, Y., Gillett, E., Fleming, M. D., Dotsch, V., Andrews, N. C., Caput, D. & McKeon, F. (1998). p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities. Molecular Cell 2, 305-316.
35. Yang, A., Schweitzer, R., Sun, D., Kaghad, M., Walker, N., Bronson, R. T., Tabin, C., Sharpe, A., Caput, D., Crum, C. & McKeon, F. (1999). p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development. Nature 398, 714-718.
36. Zeng, X., Levine, A. J. & Lu, H. (1998). Non-p53 p53RE binding protein, a human transcription factor functionally analogous to P53. Proceedings of the National Academy of Sciences, USA 95, 6681-6686.
37. Zeng, X., Chen, L., Jost, C. A., Maya, R., Keller, D., Wang, X., Kaelin, W. G., Jr, Oren, M., Chen, J. & Lu, H. (1999). MDM2 suppresses p73 function without promoting p73 degradation. Molecular and Cellular Biology 19, 3257-3266.
38. Zhu, J., Jiang, J., Zhou, W. & Chen, X. (1998). The potential tumor suppressor p73 differentially regulates cellular p53 target genes. Cancer Research 58, 5061-5065.